Dutch Chronic Pancreatitis Registry (CARE): Design and rationale of a nationwide prospective evaluation and follow-up
Usama Ahmed Ali(Radboud University Nijmegen), Marja A. Boermeester(Amsterdam University Medical Centers), Hjalmar C. van Santvoort(University Medical Center Utrecht), Anneke Roeterdink(Amsterdam UMC Location University of Amsterdam), Tom Seerden(Amphia Ziekenhuis), Adriaan C.I.T.L. Tan(Canisius-Wilhelmina Ziekenhuis), Yama Issa(Zhejiang University), Olivier R. Busch(Amsterdam Neuroscience), Marco J. Bruno(Erasmus MC), Ben Witteman(Ziekenhuis Gelderse Vallei), Hendrik M. van Dullemen(University Medical Center Groningen), Hein G. Gooszen(Cal Humanities), Cornelis H.C. Dejong(Maastricht University), Yolande C.A. Keulemans(Zuyderland Medisch Centrum), Paul Fockens(Amsterdam University Medical Centers), Joost P.H. Drenth(Amsterdam Neuroscience), Peter D. Siersema(University Medical Center Utrecht), Jeanin E. van Hooft(Leiden University Medical Center), Alexander C. Poen(Erasmus MC), Tessa E H Römkens(Jeroen Bosch Ziekenhuis), Willem Thijs(Martini Ziekenhuis), B.W.M. Spanier(Rijnstate Hospital), Jan Werner Poley(Erasmus MC), Vincent B. Nieuwenhuijs(Isala), Harry van Goor(University Medical Center Groningen), R. Timmer(St. Antonius Ziekenhuis), Casper H.J. van Eijck(Erasmus MC)
Cited by 40
Related Papers
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
|New England Journal of Medicine|2012|5.5k
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus
|New England Journal of Medicine|2002|1.6k
Treatment With the Radiolabeled Somatostatin Analog [ <sup>177</sup> Lu-DOTA <sup>0</sup> ,Tyr <sup>3</sup> ]Octreotate: Toxicity, Efficacy, and Survival
|Journal of Clinical Oncology|2008|1.4k